| Hilkert, Andreas (Thermo Fisher 201512 Senior Manager Product Marketing Inorganic Mass Spectrometry) |
Product Manager (personnel) |
Thermo Fisher (Group) |
United States (USA) |
| Hill, Adam M. (Oncimmune 201810– CEO joined 201803 before McLaren Applied Technologies) |
Chief Executive Officer (CEO) |
Oncimmune (Group) |
United Kingdom (GB) |
| Hill, Adrian (Univ Oxford 201506 Professor + Director of Jenner Institute) |
Professor |
University of Oxford |
United Kingdom (GB) |
| Hillebrand, Timo (Analytik Jena 201101 Managing Director AJ Innusreen GmbH) |
Managing Director |
IST Innuscreen GmbH |
Germany |
| Hillenkamp, Franz (Univ Münster Prof, co-inventor MALDI-TOF MS) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Hillgrove, Allan (Boehringer 201301– promoted Managing Director Div Marketing + Sales Prescription Medicines) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
| Hillisch, Alexander (Bayer HealthCare AG 200508) |
n. a. |
Bayer (Group) |
Germany |
| Hils, Martin (Zedira 201106 CEO + co-founder before N-Zyme Biotec) |
Managing Director |
Zedira GmbH |
Germany |
| Hilterhaus, Dierk (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
| Hilvert, Donald (ETH Zürich 201310 Professor at Lab for Organic Chemistry) |
Professor |
ETH Zürich (ETHZ) |
Switzerland |
| Himmler, Gottfried (f-star 200709 CEO + co-founder) |
Chief Executive Officer (CEO) |
Sino Biopharm (Group) |
Austria |
| Hing, Paul (Sensovation 201110 CTO) |
Chief Technology/Technical Officer (CTO) |
Miltenyi Biotec (Group) |
Germany |
| Hingst, Thomas (Logic Works 2001– Managing Director + Co-founder) |
Managing Director |
Logic Works GmbH |
Germany |
| Hinterding, Klaus (Proteros 201202– CSO before Roche + Novartis) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Proteros (Group) |
Germany |
| Hintsche, Rainer (2000– eBiochip Systems founder + Managing Director) |
Managing Director |
Endress+Hauser (Group) |
Germany |
| Hinzen, Berthold (Bayer 201003 Head Global BusDev + Licensing General Medicine) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
| Hinzen, Dieter (BI 200409) |
n. a. |
Boehringer Ingelheim (Group) |
Germany |
| Hippe, Alan (Roche 201104– CFO before ThyssenKrupp + Continental + Fraport) |
Chief Financial Officer (CFO) |
Roche (Group) |
Switzerland |
| Hippolyte, Christopher (Ruth Group 201612) |
Public Relations Manager / Investor Relations Manager |
Ruth Group, The (TRG) |
United States (USA) |
| Hirano, Hiro (KKR 201506 Head KKR Japan) |
President/Director/Head Business Group/Unit/Division |
KKR (Kohlberg Kravis Roberts) (Group) |
United States (USA) |
| Hirashima, Shoji (Daiichi Sankyo 201302 Managing Director of U3 Pharma GmbH) |
Managing Director |
Daiichi Sankyo (Group) |
Germany |
| Hirawat, Samit (BMS 202108 CMO before Novartis 201710 EVP + Head Global Drug Development at Novartis Oncology) |
Chief Medical Officer (CMO) |
Bristol-Myers Squibb (BMS) (Group) |
United States (USA) |
| Hirsbrunner, Fritz (Galenica –201112 CFO + Deputy CEO ) |
Chief Financial Officer (CFO) |
Galenica (Group) |
Switzerland |
| Hirsch, Christian (Showa Denko 202004 General Manager Shodex Business EMEA at Showa Denko Europe GmbH) |
General Manager (management) |
Showa Denko (SDK) (Group) |
Germany |
| Hirsch, Didier (Agilent 201007–201810 CFO at Agilent since 1999 before HP since 1989 RETIRED 10/18) |
Chief Financial Officer (CFO) |
Agilent (Group) |
United States (USA) |
| Hirsch, Hendrik (CMS 201408 Partner at CMS Hasche Sigle Ffm) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Hirsch, Volker (United Kingdom (govt) 202210– CCO at Medicines Discovery Catapult before Amadeus Capital) |
Chief Commercial Officer (CCO) |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Hirse, Thomas (CMS Hasche Sigle 2007 Attorney at CMS Hasche Sigle Düsseldorf before Linklaters LLP Köln) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Hirst, Simon (Sygnature Discovery 201112 CEO + Founder) |
Chief Executive Officer (CEO) |
Sygnature Discovery (Group) |
United Kingdom (GB) |
| Hiruta, Kazuyuki (20170823 CEO of Icon Genetics GmbH) |
Managing Director |
Denka (Group) |
Germany |
| Hitchcock, Marion (Bayer 202005 Strategic Alliance Manager at Bayer Pharmaceuticals) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
United States (USA) |
| Hitchcock, Steven (Takeda 201909 Global Head of Research) |
Research & Development Manager |
Takeda (Group) |
Japan |
| Hjortsmark, Maria (Gyros 201307 Global Marketing Director before Halo Genomics CBO) |
Sales Manager / Marketing Manager |
Mesa Laboratories (Mesa Labs) (Group) |
Sweden |
| Ho, Peter T. C. (Boston Pharmaceuticals before Epizyme + BeiGene + GSK + DuPont + Novartis) |
Business Development Manager / Strategy Manager |
BERTARELLI Group (family of Ernesto Bertarelli) |
United States (USA) |
| Ho, Selwyn (Medigene 202207– CEO before Connect Biopharma) |
Chief Executive Officer (CEO) |
Medigene (Group) |
Germany |
| Ho, Tony (CRISPR Therapeutics 201708– EVP + Head RnD) |
n. a. |
CRISPR Therapeutics (Group) |
Switzerland |
| Hobbs, Eric (Berkeley Lights 201709 CEO) |
Chief Executive Officer (CEO) |
Berkeley Lights Inc. (Nasdaq: BLI) |
United States (USA) |
| Hobe, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Hobmeier, Mike (Verve Capital Partners 202206) |
n. a. |
Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) |
Switzerland |
| Hoch, Thomas (EVP Capital 201106 Executive Board Director) |
Board member, executive |
EVP Capital Management AG |
Germany |
| Hochmair, Erwin (MED-EL Co-Founder) |
Company Founder |
MED-EL Elektromedizinische Geräte GmbH |
Austria |
| Hochmair, Ingeborg (MED-EL 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
MED-EL Elektromedizinische Geräte GmbH |
Austria |
| Hochstrasser, Denis (University Geneva 201005 Professor HUG Head Dept Genetic and Laboratory Medicine) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
| Hochuli, Tom (Vibalogics 202009– CEO before Lonza Houston) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Germany |
| Hochwimmer, Georg (SmartDyeLivery GmbH 20602 Managing Director) |
Managing Director |
SmartDyeLivery GmbH |
Germany |
| Hock, Björn (Merck (DE) 201507 Global Head Protein Engineering + Antibody Technologies at Merck Sereno) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Hock, Christoph (Neurimmune 201808– CMO before Co-Founder + Board Member main org Univ Zurich) |
Chief Medical Officer (CMO) |
Neurimmune AG |
Switzerland |
| Hodel, Svenja (Life Science Factory 202207 Communication Manager) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
| Hodits, Regina (Wellington Partners 201101– General Partner before part-time advisor before Atlas Venture until 201001) |
General Partner (venture partner) |
Wellington Partners (Group) |
Germany |
| Hoefer, Eric (Arcus Biosciences 201906– CCO before AstraZeneca + Roche/Genentech + Glaxo Wellcome) |
Chief Commercial Officer (CCO) |
Arcus Biosciences Inc. (NYSE: RCUS) |
United States (USA) |
| Hoem, Jon H. (Miracor 200806– CEO) |
Chief Executive Officer (CEO) |
Miracor (Group) |
Austria |
| Hoenlinger, Sheida (SGS 201610 Director Life Sciences Germany) |
President/Director/Head Business Group/Unit/Division |
SGS (Group) |
Switzerland |
| Hoerr, Ingmar (CureVac 201806– Chairman of Supervisory Board before 2000–201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
CureVac GmbH |
Germany |
| Hoess, Adi (Affimed 201109– CEO before CCO before Jenowis + Jerini 2003– + Carl Zeiss AG + MorphoSys AG) |
Chief Executive Officer (CEO) |
Affimed (Group) |
Germany |
| Hof, Catherine (Polyphor 201608 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Spexis (Group) |
Switzerland |
| Hofacher, Werner (Orgentec 201506 CEO) |
Chief Executive Officer (CEO) |
Orgentec (Group) |
Germany |
| Hofer, Bernhard (Oncotyrol 201105 Managing Director + CEMIT 201105 Managing Director) |
Managing Director |
OncoTyrol – Center for Personalized Cancer Medicine GmbH |
Austria |
| Hofer, Bernhard (Paion 201105–2012 CFO joined Paion Deutschland GmbH 2001 as Head Finance LEFT early 2012) |
Chief Financial Officer (CFO) |
Paion (Group) |
Germany |
| Hoff, Greg (Millipore 201008) |
n. a. |
Merck (DE) (Group) |
United States (USA) |
| Hoffman, Eric (Reveragen 201611 CEO) |
Chief Executive Officer (CEO) |
Reveragen BioPharma Inc. |
United States (USA) |
| Hoffman, Ira (HighRes Biosolutions 201801 President) |
President/Director/Head Business Group/Unit/Division |
HighRes Biosolutions Inc. |
United States (USA) |
| Hoffman, Stephen (10x Capital 201607 President before Skyline Venture + TVM Capital + Allos Therapeutics) |
General Partner (venture partner) |
Skyline Ventures |
United States (USA) |
| Hoffmann, Alexander (Merck (DE) 201807 Principal at M Ventures) |
Principal (venture capital) |
Merck (DE) (Group) |
Netherlands |
| Hoffmann, Axel-Rainer (Volkswohl Bund 202012 Board Member) |
Board member, executive |
Volkswohl Bund (Group) |
Germany |
| Hoffmann, Jörg (Wacker 201602 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Wacker (Group) |
Germany |
| Hoffmann, Karin (Bruker Corp 200909 MALDI Biotyper Marketing Bruker Daltonik GmbH) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Hoffmann, Manfred (WBG Pflegeheime 202005 Investor + Spindiag 2019– Investor) |
n. a. |
WBG Pflegeheime (DE, WBG Nursing Homes) |
Germany |
| Hoffmann, Matthias (Probiodrug 200806 VP Operations + Head IP) |
Chief Operating Officer (COO) |
Vivoryon (Group) |
Germany |
| Hoffmann, Ralf (Univ Leipzig 201001 Professor BBZ Head Bioanalytical Group) |
Professor |
University of Leipzig |
Germany |
| Hoffmann, Thomas (Phenex 201106 CFO) |
Chief Financial Officer (CFO) |
Phenex Pharmaceuticals AG |
Germany |
| Hoffmann, Thomas (Trout Group 201412) |
Public Relations Manager / Investor Relations Manager |
PNC Financial Services (Group) |
United States (USA) |
| Hoffmann, Torsten (Taros Chemicals 201810– SVP Drug Discovery before Silence Therapeutics + Zealand Pharma + Roche) |
President/Director/Head Business Group/Unit/Division |
Taros Chemicals GmbH & Co. KG |
Germany |
| Hoffmans, Raymond (SMS-Oncology 201504 Chief Business Development Manager) |
Business Development Manager / Strategy Manager |
Cato SMS (Group) |
Netherlands |
| Hoflack, Lieve (Bio Base NEW Project 201304– Project Manager) |
Cluster Manager |
Bio Base NWE project (EU Interreg IVB, 201304– 3 years) |
EU (European Union) |
| Hofmann, André (Biosaxony 201311 Managing Director before Dresden (govt) Competence Manager Life Sciences / Biotech) |
Cluster Manager |
Biosaxony Management GmbH |
Germany |
| Hofmann, Janin (Berlin (govt) 201303 Licensing Manager at Ipal GmbH) |
IP Manager |
Berlin (govt region) |
Germany |
| Hofmann, Julia (ITM 202110– Head of Corp Comms before MC Services + Medigene) |
Public Relations Manager / Investor Relations Manager |
ITM (Group) |
Germany |
| Hofmann, Siegfried |
n. a. |
Holtzbrinck (Group) |
|
| Hofmann, Thomas (TU München 201504 Professor) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Hofmann, Wera (GATC Biotech 201307 Medical Director of Life Codexx AG) |
Chief Medical Officer (CMO) |
Eurofins (Group) |
Germany |
| Hofmeister, Anton (STMicroelectronics 200509) |
n. a. |
STMicroelectronics (Group) |
Switzerland |
| Hofrichter, WIlfried (Innovand Consulting GmbH 201501 Senior Partner + Managing Director before PWC + KPMG) |
Managing Director |
Innovand Consulting GmbH |
Germany |
| Hogan, Simon (HydrogenOne 202205 Chairman) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Foresight Group (Group) |
United Kingdom (GB) |
| Hoheisel, Jörg (DKFZ Heidelberg) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Hohenberger, Jakob (Celeris Therapeutics 202202 CFO/COO + Co-Founder) |
Chief Financial Officer (CFO) |
Celeris Therapeutics (CelerixTx) (Group) |
Austria |
| Hohenhester, Michael (Curefab GmbH 2008– CEO + Co-founder) |
Chief Executive Officer (CEO) |
Curefab GmbH |
Germany |
| Hohenhoff, Gerrit (Niedersachsen (govt) 201010– Head of Office BioRegioN + Biometi e. V.) |
Regional manager |
Niedersachsen (govt region) |
Germany |
| Hohlbaum, Andreas (Pieris 201110 VP Strategic Research + Project Management before Director Science + Precl Developm) |
Research & Development Manager |
Pieris (Group) |
Germany |
| Hohlbein, Isabel (Germany (govt) 201601 Marketing + Project Manager at German Accelerator Life Sciences) |
Sales Manager / Marketing Manager |
Germany (govt) |
United States (USA) |
| Hohm, Tim (Optibrium 202002– Director of Commercial Strategy and Business Development before Novo Nordisk) |
Business Development Manager / Strategy Manager |
Optibrium (Group) |
United Kingdom (GB) |
| Hohmann, Hans-Guenter |
n. a. |
|
|
| Holdener, Eduard (Ed) (Novimmune 201512– CEO before Roche CMO) |
Chief Executive Officer (CEO) |
Novimmune S.A. |
Switzerland |
| Holland, Richard (Eagle Genomics 201201 CBO + Co-founder) |
Chief Business Officer (CBO) |
Eagle Genomics Ltd. |
United Kingdom (GB) |
| Holldack, Johanna (Kupando 202209– CEO + Founder before TreThera + Avaris + Telormedix + Borean Pharma + MediGene) |
Chief Executive Officer (CEO) |
Kupando GmbH |
Germany |
| Holley, Adrian (Thermo Fisher 201703 Marketing Director Trace Elemental Analysis at Thermo Fisher Bremen) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
Germany |
| Hollick, Jonathan (Breakpoint Therapeutics 201907 Managing Director) |
Managing Director |
Breakpoint Therapeutics GmbH |
Germany |
| Hollidt, Jörg-M. (Drug Response Dx GmbH 201301 Managing Director + in vent Diagnostika GmbH Managing Director) |
Managing Director |
Drug Response Dx GmbH (DRDx GmbH) |
Germany |
| Hollmann-Peters, Inken (Beiersdorf 201807 VP Corp Communications + Sustainability) |
Public Relations Manager / Investor Relations Manager |
Beiersdorf (Group) |
Germany |
| Holloway, Sakura (Start Codon 201907– Partner + Head of Diligence before Merck KGaA + OneVentures Pty Ltd + Benitec) |
Partner (venture partner) |
Start Codon Ltd. |
United Kingdom (GB) |
| Holmes, Elaine (Murdoch Univ 201909 Professor + leader at ANPC) |
Professor |
Murdoch University |
Australia |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 29 30 31 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
